Simoer Earns Eurofins CTF Lab Accreditation Qualification

Aug.15.2022
Simoer Earns Eurofins CTF Lab Accreditation Qualification
Simoer's analysis and testing center received CTF laboratory accreditation from Eurofins, a leading scientific analysis and certification agency.

On August 15th at 8:00 PM, Smore technology announced through its official public account, "Smore Technology", that their Smore Analysis and Testing Center for Security Assessment has received accreditation from Eurofins, a global leader in scientific analysis and testing certification, for their CTF laboratory.


Eurofins is an internationally recognized testing and certification institution with over 900 laboratories in 54 countries worldwide. They specialize in various fields including power batteries, medical devices, explosion-proof products, and industrial machinery, utilizing over 200,000 reliable analysis methods. With an impressive 450 million tests conducted annually, Eurofins is highly regarded in their industry.


The image is sourced from SIMO Technology's official public account.


According to reports, Eurofins has assessed and audited the CTF accredited laboratory for its SEMI analysis testing and safety evaluations in accordance with IECEE's requirements. The laboratory has been issued a certification of accreditation by Eurofins.


CTF, also known as Customer Testing Facilities, refers to a laboratory for testing electrical products. Smoltech has recently completed the IECEE-CB (the mutual recognition system for testing electrical products) Scheme CTF certification. After receiving this certification, Smoltech's safety tests can be mutually recognized by the 54 IECEE member countries globally. Following the unveiling of the CTF laboratory certification, customers from all over the world can access Smoltech's CTF laboratory on the IEC website. They can directly indicate the name and address of the laboratory in globally recognized CB reports.


Furthermore, Summor Analysis Testing and Safety Assessment Center also undertakes market access testing for electronic vaporizer products including the US PMTA and EU TPD.


This article contains excerpts or reprints from third-party sources. The copyright belongs to the original media and author. If there is any infringement, please contact us for removal. Any individual or organization wishing to reprint should contact the author and not republish directly.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Brazilian Government: Social Media and E-Commerce Platforms Must Remove Vape-Related Content Within 48 Hours
Brazilian Government: Social Media and E-Commerce Platforms Must Remove Vape-Related Content Within 48 Hours
Brazil’s government has given social media and e-commerce platforms 48 hours to take down content and offers related to e-cigarettes. The order, issued by the National Council to Combat Piracy and Intellectual Property Crimes (CNCP), is part of a nationwide crackdown on illegal online sales and advertising of vaping products. Companies must also file compliance reports within ten business days or face penalties.
Aug.25 by 2FIRSTS.ai
2Firsts Exclusive: Dr. Zdinak Analyzes FDA’s Rejection of blu, Citing Lack of Behavioral Evidence
2Firsts Exclusive: Dr. Zdinak Analyzes FDA’s Rejection of blu, Citing Lack of Behavioral Evidence
In a 2Firsts exclusive, ARAC’s Dr. Zdinak explains FDA’s blu rejection stems from weak behavioral science data and urges companies to strengthen Module 6 studies immediately.
Aug.20
PIXL ranks among the top three best-selling e-cigarettes in Scotland, with 2Firsts analyzing the product and growth logic
PIXL ranks among the top three best-selling e-cigarettes in Scotland, with 2Firsts analyzing the product and growth logic
SLR reports on Talysis data, revealing Pixl as Scotland's third best-selling e-cigarette brand with 13.5% market share.
Aug.07 by 2FIRSTS.ai
2Firsts Exclusive with Former WHO Director Tikki Pang: FCTC Overlooks Tobacco Harm Reduction, and Asia’s Tobacco Control Challenges Demand Urgent Solutions
2Firsts Exclusive with Former WHO Director Tikki Pang: FCTC Overlooks Tobacco Harm Reduction, and Asia’s Tobacco Control Challenges Demand Urgent Solutions
Ahead of AFN25, 2Firsts interviewed former WHO director Tikki Pang, who reflected on two decades of the FCTC. While acknowledging its early successes, Pang pointed to its greatest shortcoming—excluding tobacco harm reduction—and noted its limited impact in Asia. He called for advancing THR and emphasized that proper regulation should balance reducing risks for adults and preventing youth access, while ensuring affordability and curbing illicit trade.
Aug.26
Legal Commentary: FDA Approves JUUL Menthol E-Cigarettes and Releases Key Scientific Evaluation Criteria
Legal Commentary: FDA Approves JUUL Menthol E-Cigarettes and Releases Key Scientific Evaluation Criteria
2Firsts received a legal commentary from lawyer Zheng Mingwei’s team, analyzing the FDA’s approval of JUUL menthol e-cigarettes. The article outlines key scientific data, regulatory standards, and industry implications.
Jul.22
Singapore to Classify Etomidate as Class C Drug from September; Importers and Sellers Face Up to 20 Years in Prison
Singapore to Classify Etomidate as Class C Drug from September; Importers and Sellers Face Up to 20 Years in Prison
Singapore will classify the anesthetic etomidate as a Class C drug from September 1, with traffickers and users facing prosecution and a minimum one-year jail term. The move comes amid growing concerns over the health risks posed by etomidate-laced e-cigarettes, which have become increasingly popular. The government has stepped up enforcement efforts, seizing over 850 e-cigarettes in recent operations.
Aug.25 by 2FIRSTS.ai